INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 May 2012
Total net assets |
£121.4m |
NAV per share |
218.8p |
Share price |
184.3p |
Total value of unquoted investments |
£24.3m |
Total number of portfolio companies |
66 |
Cash |
6% NAV |
Cash committed and reserved to unquoted investments |
(5)% NAV |
Portfolio companies with < 1 year of cash |
15% NAV |
Top Ten Holdings
Company Name |
% NAV |
Amgen Aptiv Solutions |
6.2 4.8 |
Celgene Alexion EUSA |
4.5 3.8 3.7 |
Teva |
3.6 |
Insulet Biogen Biomarin |
3.5 3.4 3.3 |
Pharmaxis |
3.2 |
|
----------- |
Total |
40 |
Geographical Allocation |
% |
United States & Canada |
74 |
Europe |
13 |
Israel Australia |
4 3 |
Cash |
6 |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
74 |
Unquoted |
20 |
Cash |
6 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
22 JUNE 2012